Ads by Google
Repors examines policy options that would help increase generic drug use and decrease costs for the Medicare prescription drug benefit.
Study finds higher cost sharing reduces treatment adherence and drug usage.
The House later this month is expected to debate reauthorization of the Prescription Drug User Fee Act, which since its passage in 1992 has been a "huge success" in speeding FDA approval times for new prescription drugs, the Washington Post reports. The Senate recently approved a bill (S 1082) that includes a five-year reauthorization of PDUFA.
Abbott Laboratories has agreed to reduce the cost of its antiretroviral drug Kaletra in Brazil by about 30%.
FDA has granted final approval for Caraco Pharmaceutical's Abbreviated New Drug Application for paroxetine hydrochloride tablets, USP (Paroxetine HCl).
FDA approved the first generic versions of prescription Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis).
FDA continues to warn the American public about the dangers of buying medications over the Internet.
Mylan Pharmaceuticals has received final approval from the FDA for its Abbreviated New Drug Application for Terbinafine Hydrochloride Tablets, 250 mg (base).
Research demonstrated the power of new drug technology being developed by Centrose biopharmaceutical start-up, to overcome the increasingly vexing problem of drug resistance.
Patients who fill their prescriptions while traveling abroad need to be cautious.
Actavis Group has launched NIFEdipine extended-release tablets. Distribution of the product will commence immediately.
SYMBICORT (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older.
Ferring Pharmaceuticals has received approval from the U.S. Food and Drug Administration to market ENDOMETRIN (progesterone) Vaginal Insert, 100 mg.
The House Energy and Commerce Committee Thursday overwhelmingly passed a major package of prescription drug safety reforms.
U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant.
Journal Science will publish results of research that details Anacor Pharmaceuticals' how AN2690 kills fungal cells by interfering with synthesis of a specific protein required for fungal growth.
SyntheMed has been informed by the US Food and Drug Administration that it will review the Company's Pre-market Approval application for REPEL-CV Adhesion Barrier.
House Energy and Commerce Health Subcommittee approved nine bills that would expand FDA's authority to regulate prescription drug safety.
Half of all adults in the U.S. still believe that the FDA is doing a fair or poor job when it comes to ensuring the safety and efficacy of new prescription drugs.
Slicing certain pills in half could slice a hefty amount off of America's prescription drug costs.
Center for Molecular Medicine is the first Midwest-based laboratory to offer the FDA-approved AmpliChip CYP450 Test to physicians and hospitals.
Orange County residents of the Emergency Planning Zone who did not have an opportunity to participate in two previous KI distributions can still receive KI pills at no charge.
U.S. Food and Drug Administration has granted final approval for Lupin Pharmaceuticals's Abbreviated New Drug Application for Trandolapril Tablets, 1mg, 2mg and 4mg.
Shasta County launched a prescription discount card program to help consumers cope with the high price of prescription drugs.
Barr Laboratories announced the dismissal of litigation related to its challenge of the patent protecting Eli Lilly and Company's ZYPREXA Zydis (Olanzapine) Orally Disintegrating Tablets, 5mg, 10mg, 15mg and 20mg.
Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Doxycycline Tablets, 150 mg.
Hong Kong Department of Health called on members of the public not to buy or use a brand of health product called 'Junyu Jiaonanyihao', which was found to have contained undeclared western drug ingredients that may cause side effects.
The US pharmaceutical industry should brace itself for change as Americans become more involved in choosing their own prescription drugs.
The first initiative to be undertaken by ACI and Sanovia will be to develop a library of evidence- based guidelines for the appropriate use of high-cost pharmaceuticals and biotech products.
Over one hundred Long Island AARP members gathered to rally state lawmakers to pass legislation before the end of the 2007 Legislative Session in Albany that will help make prescription drugs more affordable and help assure that their cell phone works in an emergency.